vs

Side-by-side financial comparison of Evolv Technologies Holdings, Inc. (EVLV) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

Evolv Technologies Holdings, Inc. is the larger business by last-quarter revenue ($38.5M vs $32.6M, roughly 1.2× RxSight, Inc.). Evolv Technologies Holdings, Inc. runs the higher net margin — 28.3% vs -28.1%, a 56.3% gap on every dollar of revenue. On growth, Evolv Technologies Holdings, Inc. posted the faster year-over-year revenue change (32.3% vs -18.9%). Over the past eight quarters, Evolv Technologies Holdings, Inc.'s revenue compounded faster (31.8% CAGR vs 5.1%).

Sentient Technologies was an American artificial intelligence technology company based in San Francisco. Sentient was founded in 2007 and received over $143 million in funding at different points after its inception. As of 2016, Sentient was the world's most well-funded AI company. It focused on e-commerce, online content and trading.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

EVLV vs RXST — Head-to-Head

Bigger by revenue
EVLV
EVLV
1.2× larger
EVLV
$38.5M
$32.6M
RXST
Growing faster (revenue YoY)
EVLV
EVLV
+51.2% gap
EVLV
32.3%
-18.9%
RXST
Higher net margin
EVLV
EVLV
56.3% more per $
EVLV
28.3%
-28.1%
RXST
Faster 2-yr revenue CAGR
EVLV
EVLV
Annualised
EVLV
31.8%
5.1%
RXST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EVLV
EVLV
RXST
RXST
Revenue
$38.5M
$32.6M
Net Profit
$10.9M
$-9.2M
Gross Margin
48.4%
77.5%
Operating Margin
-20.7%
-34.8%
Net Margin
28.3%
-28.1%
Revenue YoY
32.3%
-18.9%
Net Profit YoY
169.2%
-54.1%
EPS (diluted)
$0.07
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EVLV
EVLV
RXST
RXST
Q4 25
$38.5M
$32.6M
Q3 25
$42.9M
$30.3M
Q2 25
$32.5M
$33.6M
Q1 25
$32.0M
$37.9M
Q4 24
$29.1M
$40.2M
Q3 24
$27.4M
$35.3M
Q2 24
$25.2M
$34.9M
Q1 24
$22.2M
$29.5M
Net Profit
EVLV
EVLV
RXST
RXST
Q4 25
$10.9M
$-9.2M
Q3 25
$-1.8M
$-9.8M
Q2 25
$-40.5M
$-11.8M
Q1 25
$-1.7M
$-8.2M
Q4 24
$-15.7M
$-5.9M
Q3 24
$-30.4M
$-6.3M
Q2 24
$3.4M
$-6.1M
Q1 24
$-11.3M
$-9.1M
Gross Margin
EVLV
EVLV
RXST
RXST
Q4 25
48.4%
77.5%
Q3 25
49.7%
79.9%
Q2 25
49.8%
74.9%
Q1 25
59.8%
74.8%
Q4 24
57.5%
71.6%
Q3 24
57.8%
71.4%
Q2 24
58.5%
69.5%
Q1 24
54.8%
70.1%
Operating Margin
EVLV
EVLV
RXST
RXST
Q4 25
-20.7%
-34.8%
Q3 25
-20.1%
-40.1%
Q2 25
-53.8%
-41.6%
Q1 25
-45.0%
-28.2%
Q4 24
-64.9%
-21.5%
Q3 24
-70.0%
-26.1%
Q2 24
-88.7%
-23.9%
Q1 24
-98.8%
-36.2%
Net Margin
EVLV
EVLV
RXST
RXST
Q4 25
28.3%
-28.1%
Q3 25
-4.2%
-32.4%
Q2 25
-124.6%
-35.0%
Q1 25
-5.3%
-21.6%
Q4 24
-54.0%
-14.8%
Q3 24
-111.3%
-17.9%
Q2 24
13.6%
-17.4%
Q1 24
-50.8%
-30.8%
EPS (diluted)
EVLV
EVLV
RXST
RXST
Q4 25
$0.07
$-0.22
Q3 25
$-0.01
$-0.24
Q2 25
$-0.25
$-0.29
Q1 25
$-0.01
$-0.20
Q4 24
$-0.10
$-0.14
Q3 24
$-0.19
$-0.16
Q2 24
$0.02
$-0.16
Q1 24
$-0.07
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EVLV
EVLV
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$49.1M
$228.1M
Total DebtLower is stronger
$28.6M
Stockholders' EquityBook value
$119.4M
$275.7M
Total Assets
$304.4M
$311.8M
Debt / EquityLower = less leverage
0.24×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EVLV
EVLV
RXST
RXST
Q4 25
$49.1M
$228.1M
Q3 25
$56.2M
$227.5M
Q2 25
$36.9M
$227.5M
Q1 25
$35.0M
$229.3M
Q4 24
$51.9M
$237.2M
Q3 24
$56.0M
$237.1M
Q2 24
$56.5M
$233.3M
Q1 24
$81.0M
$125.4M
Total Debt
EVLV
EVLV
RXST
RXST
Q4 25
$28.6M
Q3 25
$28.5M
Q2 25
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EVLV
EVLV
RXST
RXST
Q4 25
$119.4M
$275.7M
Q3 25
$102.2M
$276.0M
Q2 25
$92.7M
$278.0M
Q1 25
$121.1M
$279.3M
Q4 24
$117.7M
$281.2M
Q3 24
$129.0M
$277.3M
Q2 24
$151.2M
$275.2M
Q1 24
$139.8M
$163.9M
Total Assets
EVLV
EVLV
RXST
RXST
Q4 25
$304.4M
$311.8M
Q3 25
$304.3M
$308.5M
Q2 25
$280.4M
$309.0M
Q1 25
$256.0M
$313.0M
Q4 24
$268.1M
$318.6M
Q3 24
$278.5M
$310.5M
Q2 24
$269.1M
$305.5M
Q1 24
$280.0M
$183.2M
Debt / Equity
EVLV
EVLV
RXST
RXST
Q4 25
0.24×
Q3 25
0.28×
Q2 25
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EVLV
EVLV
RXST
RXST
Operating Cash FlowLast quarter
$15.6M
$-1.1M
Free Cash FlowOCF − Capex
$-2.3M
FCF MarginFCF / Revenue
-6.9%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
1.43×
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EVLV
EVLV
RXST
RXST
Q4 25
$15.6M
$-1.1M
Q3 25
$3.5M
$-1.2M
Q2 25
$2.1M
$-4.4M
Q1 25
$-2.5M
$-8.8M
Q4 24
$3.2M
$-4.3M
Q3 24
$3.7M
$650.0K
Q2 24
$-21.6M
$-4.0M
Q1 24
$-16.2M
$-9.3M
Free Cash Flow
EVLV
EVLV
RXST
RXST
Q4 25
$-2.3M
Q3 25
$-1.8M
Q2 25
$-5.9M
Q1 25
$-9.4M
Q4 24
$-5.1M
Q3 24
$-453.0K
Q2 24
$-5.5M
Q1 24
$-11.3M
FCF Margin
EVLV
EVLV
RXST
RXST
Q4 25
-6.9%
Q3 25
-5.8%
Q2 25
-17.6%
Q1 25
-24.8%
Q4 24
-12.7%
Q3 24
-1.3%
Q2 24
-15.9%
Q1 24
-38.2%
Capex Intensity
EVLV
EVLV
RXST
RXST
Q4 25
3.5%
Q3 25
1.9%
Q2 25
4.6%
Q1 25
1.5%
Q4 24
2.1%
Q3 24
3.1%
Q2 24
4.4%
Q1 24
6.7%
Cash Conversion
EVLV
EVLV
RXST
RXST
Q4 25
1.43×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-6.31×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EVLV
EVLV

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons